Potential for coronary CT angiography to tailor medical therapy beyond preventive guideline-based recommendations: Insights from the ROMICAT I trial

摘要: Abstract Background Coronary CT angiography (CCTA) is used in the emergency department to rule out acute coronary syndrome low-intermediate risk patients. Objectives We evaluated potential of CCTA tailor aspirin (ASA) and statin therapy chest pain Methods included all patients ROMICAT I trial who underwent before admission. Results were blinded caretakers. documented ASA at admission discharge determined change medications during hospitalization, agreement with contemporaneous guidelines, presence severity artery disease (CAD) as by CCTA. 368 (53 ± 12 years; 61% male). Baseline medical presentation 27% on 24% statin. Most qualified for secondary prevention (95% 80%, respectively), whereas among those qualifying primary therapy, only 59% 33% discharge. Excluding patients, CCTA-detected CAD, 66/131 (50%) 53/131 (40%) Conversely, without 54/156 (35%) 20/151 (13%) Conclusion There are significant discrepancies between prescription extent CAD. presents an efficient opportunity CAD undergoing part their evaluation.